ID

37583

Beschreibung

The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01887353

Link

https://clinicaltrials.gov/show/NCT01887353

Stichworte

  1. 08.08.19 08.08.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. August 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Atrial Fibrillation NCT01887353

Eligibility Atrial Fibrillation NCT01887353

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or non-pregnant female > 18 years of age;
Beschreibung

Gender | Gender Pregnancy Absent | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0032961
UMLS CUI [2,3]
C0332197
UMLS CUI [3]
C0001779
documentation of heart failure and who are in nyha class ii or iii;
Beschreibung

Heart failure New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
documented history of symptomatic af < 6 months in duration at the time of presentation, currently in af at the time of the external electrical cardioversion, and successfully restored to normal sinus rhythm;
Beschreibung

ATRIAL FIBRILLATION SYMPTOMATIC Duration | External elective cardioversion | Sinus rhythm Restore Successful

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0741283
UMLS CUI [1,2]
C0449238
UMLS CUI [2]
C2191347
UMLS CUI [3,1]
C0232201
UMLS CUI [3,2]
C1283255
UMLS CUI [3,3]
C1272703
percutaneous coronary intervention (pci) patients who can be placed on anticoagulation with warfarin post-cardioversion (and not on rivaroxaban or dabigatran);
Beschreibung

Percutaneous Coronary Intervention | Anticoagulation Therapy | Warfarin | Status post Electric Countershock

Datentyp

boolean

Alias
UMLS CUI [1]
C1532338
UMLS CUI [2]
C0003281
UMLS CUI [3]
C0043031
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0013778
demonstration of preserved ejection fraction (ef) by echocardiography;
Beschreibung

Cardiac ejection fraction Echocardiography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0013516
echocardiographic evidence of impaired diastolic filling.
Beschreibung

Filling period.diastole Impaired Echocardiography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0806126
UMLS CUI [1,2]
C0221099
UMLS CUI [1,3]
C0013516
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known history of permanent or long-standing af (> 6 months);
Beschreibung

Permanent atrial fibrillation Disease length | Atrial Fibrillation Long-term Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2586056
UMLS CUI [1,2]
C0872146
UMLS CUI [2,1]
C0004238
UMLS CUI [2,2]
C0443252
UMLS CUI [2,3]
C0872146
other acutely reversible causes of af, including but not limited to: hyperthyroidism, pericarditis, myocarditis or pulmonary embolism;
Beschreibung

Causes Reversible Atrial Fibrillation | Hyperthyroidism | Pericarditis | Myocarditis | Pulmonary Embolism

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0205343
UMLS CUI [1,3]
C0004238
UMLS CUI [2]
C0020550
UMLS CUI [3]
C0031046
UMLS CUI [4]
C0027059
UMLS CUI [5]
C0034065
known history of cirrhosis;
Beschreibung

Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
nyha class iv;
Beschreibung

New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C1275491
myocardial infarction, unstable angina, or coronary artery bypass graft surgery within three months prior to screening;
Beschreibung

Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery

Datentyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0010055
percutaneous coronary intervention (pci) within 4 weeks prior to screening, if these patients need to be placed on rivaroxaban or dabigatran post-cardioversion;
Beschreibung

Percutaneous Coronary Intervention | Patient need for Rivaroxaban | Patient need for Dabigatran | Status post Electric Countershock

Datentyp

boolean

Alias
UMLS CUI [1]
C1532338
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C1739768
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C2348066
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0013778
clinically significant valvular disease;
Beschreibung

Valvular disease

Datentyp

boolean

Alias
UMLS CUI [1]
C3258293
clinically significant pulmonary disease;
Beschreibung

Lung disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0024115
stroke within 3 months prior to screening;
Beschreibung

Cerebrovascular accident

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
creatinine clearance < 30 ml/min as calculated by cockcroft-gault formula;
Beschreibung

Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1]
C2711451
use of anti-arrhythmic drugs (class ia or iiic) within 3 months prior to screening;
Beschreibung

Anti-Arrhythmia Agents Class

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003195
UMLS CUI [1,2]
C0456387
concurrent use of drugs considered strong inhibitors of cyp3a;
Beschreibung

CYP3A Inhibitors Strong

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3850056
UMLS CUI [1,2]
C0442821
concurrent use of drugs considered as cyp3a inducers;
Beschreibung

CYP3A Inducers

Datentyp

boolean

Alias
UMLS CUI [1]
C3850044
prior treatment with ranolazine.
Beschreibung

ranolazine

Datentyp

boolean

Alias
UMLS CUI [1]
C0073633

Ähnliche Modelle

Eligibility Atrial Fibrillation NCT01887353

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Gender Pregnancy Absent | Age
Item
male or non-pregnant female > 18 years of age;
boolean
C0079399 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0001779 (UMLS CUI [3])
Heart failure New York Heart Association Classification
Item
documentation of heart failure and who are in nyha class ii or iii;
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
ATRIAL FIBRILLATION SYMPTOMATIC Duration | External elective cardioversion | Sinus rhythm Restore Successful
Item
documented history of symptomatic af < 6 months in duration at the time of presentation, currently in af at the time of the external electrical cardioversion, and successfully restored to normal sinus rhythm;
boolean
C0741283 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2191347 (UMLS CUI [2])
C0232201 (UMLS CUI [3,1])
C1283255 (UMLS CUI [3,2])
C1272703 (UMLS CUI [3,3])
Percutaneous Coronary Intervention | Anticoagulation Therapy | Warfarin | Status post Electric Countershock
Item
percutaneous coronary intervention (pci) patients who can be placed on anticoagulation with warfarin post-cardioversion (and not on rivaroxaban or dabigatran);
boolean
C1532338 (UMLS CUI [1])
C0003281 (UMLS CUI [2])
C0043031 (UMLS CUI [3])
C0231290 (UMLS CUI [4,1])
C0013778 (UMLS CUI [4,2])
Cardiac ejection fraction Echocardiography
Item
demonstration of preserved ejection fraction (ef) by echocardiography;
boolean
C0232174 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Filling period.diastole Impaired Echocardiography
Item
echocardiographic evidence of impaired diastolic filling.
boolean
C0806126 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0013516 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Permanent atrial fibrillation Disease length | Atrial Fibrillation Long-term Disease length
Item
known history of permanent or long-standing af (> 6 months);
boolean
C2586056 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0004238 (UMLS CUI [2,1])
C0443252 (UMLS CUI [2,2])
C0872146 (UMLS CUI [2,3])
Causes Reversible Atrial Fibrillation | Hyperthyroidism | Pericarditis | Myocarditis | Pulmonary Embolism
Item
other acutely reversible causes of af, including but not limited to: hyperthyroidism, pericarditis, myocarditis or pulmonary embolism;
boolean
C0015127 (UMLS CUI [1,1])
C0205343 (UMLS CUI [1,2])
C0004238 (UMLS CUI [1,3])
C0020550 (UMLS CUI [2])
C0031046 (UMLS CUI [3])
C0027059 (UMLS CUI [4])
C0034065 (UMLS CUI [5])
Liver Cirrhosis
Item
known history of cirrhosis;
boolean
C0023890 (UMLS CUI [1])
New York Heart Association Classification
Item
nyha class iv;
boolean
C1275491 (UMLS CUI [1])
Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery
Item
myocardial infarction, unstable angina, or coronary artery bypass graft surgery within three months prior to screening;
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
Percutaneous Coronary Intervention | Patient need for Rivaroxaban | Patient need for Dabigatran | Status post Electric Countershock
Item
percutaneous coronary intervention (pci) within 4 weeks prior to screening, if these patients need to be placed on rivaroxaban or dabigatran post-cardioversion;
boolean
C1532338 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C1739768 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C2348066 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0013778 (UMLS CUI [4,2])
Valvular disease
Item
clinically significant valvular disease;
boolean
C3258293 (UMLS CUI [1])
Lung disease
Item
clinically significant pulmonary disease;
boolean
C0024115 (UMLS CUI [1])
Cerebrovascular accident
Item
stroke within 3 months prior to screening;
boolean
C0038454 (UMLS CUI [1])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine clearance < 30 ml/min as calculated by cockcroft-gault formula;
boolean
C2711451 (UMLS CUI [1])
Anti-Arrhythmia Agents Class
Item
use of anti-arrhythmic drugs (class ia or iiic) within 3 months prior to screening;
boolean
C0003195 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
CYP3A Inhibitors Strong
Item
concurrent use of drugs considered strong inhibitors of cyp3a;
boolean
C3850056 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
CYP3A Inducers
Item
concurrent use of drugs considered as cyp3a inducers;
boolean
C3850044 (UMLS CUI [1])
ranolazine
Item
prior treatment with ranolazine.
boolean
C0073633 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video